Vol 7, No 4 (2018)
Research paper
Published online: 2018-09-11

open access

Page views 5961
Article views/downloads 906
Get Citation

Connect on Social Media

Connect on Social Media

Accessibility to personal insulin pumps among children with diabetes mellitus in Poland in 2014

Artur Myśliwiec1, Przemysława Jarosz-Chobot2, Małgorzata Myśliwiec3, Krzysztof Strojek4, Paweł Piątkiewicz5, Mieczysław Walczak6, Władysław Grzeszczak7, Beata Koń8, Milena Kozioł8, Barbara Więckowska8
Clin Diabetol 2018;7(4):175-181.

Abstract

One of the principal aspects of comprehensive medical care for patients with diabetes mellitus, especially paediatric patients, is the accessibility to personal insulin pumps. In Poland, the National Health Fund secures personal insulin pumps for children by means of a separately commissioned service. The structure of the provided services varies greatly from province to province in terms of accessibility to insulin pumps.

Article available in PDF format

View PDF Download PDF file

References

  1. Chobot A, Polanska J, Brandt A, et al. Updated 24-year trend of Type 1 diabetes incidence in children in Poland reveals a sinusoidal pattern and sustained increase. Diabet Med. 2017; 34(9): 1252–1258.
  2. Steineck I, Cederholm J, Eliasson B, et al. Swedish National Diabetes Register. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ. 2015; 350: h3234.
  3. Benkhadra K, Alahdab F, Tamhane SU, et al. Continuous subcutaneous insulin infusion versus multiple daily injections in individuals with type 1 diabetes: a systematic review and meta-analysis. Endocrine. 2017; 55(1): 77–84.
  4. Bolderman KM. Putting Your Patients on the Pump. Initiation and Maintenance Guidelines. American Diabetes Association, Aleksandria. (VA): 2013.
  5. Danne T, Bangstad H, et al. J., Deeb L. : Insulin treatment, ISPAD Clinical Practice Consensus Guidelines, 2014. Pediatric Diabetes. 2014; 15(supl. 20): 115–134.
  6. Danne T, Bangstad HJ, Deeb L, et al. International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2014; 15 Suppl 20: 115–134.
  7. Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008; 25(7): 765–774.
  8. Thabit H, Hovorka R. Continuous subcutaneous insulin infusion therapy and multiple daily insulin injections in type 1 diabetes mellitus: a comparative overview and future horizons. Expert Opin Drug Deliv. 2016; 13(3): 389–400.
  9. Zarządzenie Prezesa Narodowego Funduszu Zdrowia Nr 106/2008/DSOZ z dnia 26 listopada 2008 r. w sprawie określenia warunków zawierania i realizacji umów w rodzaju świadczenia zdrowotne kontraktowane odrębnie.
  10. Zarządzenie Prezesa Narodowego Funduszu Zdrowia Nr 67/2011/DSOZ z dnia 18 października 2011 r. w sprawie określenia warunków zawierania i realizacji umów w rodzaju świadczenia zdrowotne kontraktowane odrębnie.
  11. Centrum Systemów Informacyjnych Ochrony Zdrowia, (2008) Międzynarodowa Statystyczna Klasyfikacja Chorób i Problemów Zdrowotnych. Rewizja dziesiąta Tom I.
  12. Steineck I, Cederholm J, Eliasson B, et al. Swedish National Diabetes Register. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. BMJ. 2015; 350: h3234.
  13. de Beaufort CE, Swift PGF, Skinner CT, et al. Hvidoere Study Group on Childhood Diabetes 2005. Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care. 2007; 30(9): 2245–2250.
  14. https://www.wosp.org.pl/medycyna/programy/cukrzyca-dzieci. (08.05.2018).